Learn More
Invitrogen™ Connexin 36 Recombinant Rabbit Monoclonal Antibody (2H12L14)
Description
Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
Specifications
Specifications
| Antigen | Connexin 36 |
| Applications | Western Blot, Immunocytochemistry |
| Classification | Recombinant Monoclonal |
| Clone | 2H12L14 |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.09% sodium azide; pH 7.2 |
| Gene | GJD2 |
| Gene Accession No. | O70610, Q9UKL4 |
| Gene Alias | connexin 36; connexin36; connexin-36; cx36; Gap junction alpha-9 protein; gap junction delta-2 protein; gap junction membrane channel protein alpha 9; gap junction protein delta 2; gap junction protein, alpha 9; gap junction protein, delta 2; gap junction protein, delta 2, 36kDa; GJA10; Gja9; GJD2 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.